Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors.
Targeting papain family cysteine proteases is one of the novel strategies in the development of chemotherapy for a number of diseases. Novel cysteine protease inhibitors derived from 1-pyridylimidazo[1,5-a]pyridine representing pharmacologically important class of compounds are being reported here f...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec339d7965d944c58db256d573dc26df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ec339d7965d944c58db256d573dc26df |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ec339d7965d944c58db256d573dc26df2021-11-18T09:01:25ZDesign, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors.1932-620310.1371/journal.pone.0069982https://doaj.org/article/ec339d7965d944c58db256d573dc26df2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23940536/?tool=EBIhttps://doaj.org/toc/1932-6203Targeting papain family cysteine proteases is one of the novel strategies in the development of chemotherapy for a number of diseases. Novel cysteine protease inhibitors derived from 1-pyridylimidazo[1,5-a]pyridine representing pharmacologically important class of compounds are being reported here for the first time. The derivatives were initially designed and screened in silico by molecular docking studies against papain to explore the possible mode of action. The molecular interaction between the compounds and cysteine protease (papain) was found to be very similar to the interactions observed with the respective epoxide inhibitor (E-64c) of papain. Subsequently, compounds were synthesized to validate their efficacy in wet lab experiments. When characterized kinetically, these compounds show their Ki and IC50 values in the range of 13.75 to 99.30 µM and 13.40 to 96.50 µM, respectively. The thermodynamics studies suggest their binding with papain hydrophobically and entropically driven. These inhibitors also inhibit the growth of clinically important different types of Gram positive and Gram negative bacteria having MIC50 values in the range of 0.6-1.4 µg/ml. Based on Lipinski's rule of Five, we also propose these compounds as potent antibacterial prodrugs. The most active antibacterial compound was found to be 1-(2-pyridyl)-3-(2-hydroxyphenyl)imidazo[1,5-a]pyridine (3a).Mohd Sajid KhanMohd Hassan BaigSaheem AhmadShapi Ahmad SiddiquiAshwini Kumar SrivastavaKumar Venkatraman SrinivasanIrfan A AnsariPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e69982 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mohd Sajid Khan Mohd Hassan Baig Saheem Ahmad Shapi Ahmad Siddiqui Ashwini Kumar Srivastava Kumar Venkatraman Srinivasan Irfan A Ansari Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
description |
Targeting papain family cysteine proteases is one of the novel strategies in the development of chemotherapy for a number of diseases. Novel cysteine protease inhibitors derived from 1-pyridylimidazo[1,5-a]pyridine representing pharmacologically important class of compounds are being reported here for the first time. The derivatives were initially designed and screened in silico by molecular docking studies against papain to explore the possible mode of action. The molecular interaction between the compounds and cysteine protease (papain) was found to be very similar to the interactions observed with the respective epoxide inhibitor (E-64c) of papain. Subsequently, compounds were synthesized to validate their efficacy in wet lab experiments. When characterized kinetically, these compounds show their Ki and IC50 values in the range of 13.75 to 99.30 µM and 13.40 to 96.50 µM, respectively. The thermodynamics studies suggest their binding with papain hydrophobically and entropically driven. These inhibitors also inhibit the growth of clinically important different types of Gram positive and Gram negative bacteria having MIC50 values in the range of 0.6-1.4 µg/ml. Based on Lipinski's rule of Five, we also propose these compounds as potent antibacterial prodrugs. The most active antibacterial compound was found to be 1-(2-pyridyl)-3-(2-hydroxyphenyl)imidazo[1,5-a]pyridine (3a). |
format |
article |
author |
Mohd Sajid Khan Mohd Hassan Baig Saheem Ahmad Shapi Ahmad Siddiqui Ashwini Kumar Srivastava Kumar Venkatraman Srinivasan Irfan A Ansari |
author_facet |
Mohd Sajid Khan Mohd Hassan Baig Saheem Ahmad Shapi Ahmad Siddiqui Ashwini Kumar Srivastava Kumar Venkatraman Srinivasan Irfan A Ansari |
author_sort |
Mohd Sajid Khan |
title |
Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
title_short |
Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
title_full |
Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
title_fullStr |
Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
title_full_unstemmed |
Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
title_sort |
design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/ec339d7965d944c58db256d573dc26df |
work_keys_str_mv |
AT mohdsajidkhan designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors AT mohdhassanbaig designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors AT saheemahmad designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors AT shapiahmadsiddiqui designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors AT ashwinikumarsrivastava designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors AT kumarvenkatramansrinivasan designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors AT irfanaansari designsynthesisevaluationandthermodynamicsof1substitutedpyridylimidazo15apyridinederivativesascysteineproteaseinhibitors |
_version_ |
1718421058254536704 |